Johns Hopkins University School of Medicine.
Children's National Health System.
J Pediatr Psychol. 2019 Jan 1;44(1):40-51. doi: 10.1093/jpepsy/jsy073.
To investigate longitudinal associations of health beliefs, which included self-efficacy, outcome expectancies, and perceived barriers, and demographic risk factors (i.e., age, gender, race, and family income) with antihypertensive medication adherence in adolescents with chronic kidney disease (CKD) over 24 months.
The sample included 114 adolescents (M age = 15.03 years, SD = 2.44) diagnosed with CKD. Adolescents reported their self-efficacy for taking medications, medication outcome expectancies, and barriers to adherence at baseline and 12 and 24 months after baseline. Antihypertensive medication adherence was assessed via electronic monitoring for 2 weeks at baseline and 6, 12, 18, and 24 months after baseline.
Adherence increased and then decreased over the 2-year study period (inverted U-shape). Self-efficacy, outcome expectancies, and barriers did not change over time. Older adolescent age, female gender, African American race, <$50,000 annual family income, and public health insurance were associated with lower adherence. However, family income was the primary demographic risk factor that predicted adherence over time (≥$50,000 annual family income was longitudinally associated with higher adherence). Higher self-efficacy and more positive and less negative outcome expectancies across time were also associated with higher antihypertensive medication adherence across time.
Clinical interventions should be developed to target medication self-efficacy and outcome expectancies to improve long-term antihypertensive medication adherence in adolescents with CKD. Family income may be considered when conceptualizing contextual factors that likely contribute to adolescents' consistent challenges with medication adherence over time.
探讨健康信念(包括自我效能、预期结果和感知障碍)以及人口统计学风险因素(年龄、性别、种族和家庭收入)与青少年慢性肾脏病(CKD)患者 24 个月内抗高血压药物依从性的纵向关联。
该样本包括 114 名被诊断为 CKD 的青少年(M 年龄=15.03 岁,SD=2.44)。青少年在基线以及基线后 12 个月和 24 个月时报告其服药自我效能、药物预期结果和依从障碍。通过电子监测在基线以及基线后 6、12、18 和 24 个月评估抗高血压药物的依从性。
依从性在 2 年的研究期间呈先增加后减少的趋势(倒 U 形)。自我效能、预期结果和障碍在时间上没有变化。青少年年龄较大、女性、非裔美国人、家庭收入<50000 美元、公共医疗保险与较低的依从性相关。然而,家庭收入是预测依从性随时间变化的主要人口统计学风险因素(家庭收入≥50000 美元与较高的依从性随时间相关)。较高的自我效能以及更积极和更少消极的预期结果与随时间的抗高血压药物依从性增加相关。
应制定临床干预措施以提高青少年 CKD 患者的药物自我效能和预期结果,以改善长期抗高血压药物的依从性。在考虑可能导致青少年长期用药依从性持续挑战的背景因素时,可能需要考虑家庭收入。